XML 32 R16.htm IDEA: XBRL DOCUMENT v3.25.2
GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS
 12 Months Ended
Jun. 30, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS
The changes in the carrying amount of goodwill by reportable segment and Corporate and Other for the fiscal years ended June 30, 2025 and 2024 were as follows:
Goodwill
Health and Wellness
HouseholdLifestyleInternational
Corporate and Other
Total
Balance as of June 30, 2023$323 $85 $244 $600 $— $1,252 
Divestiture (1)
— — — (16)— (16)
Effect of foreign currency translation— — — (8)— (8)
Balance as of June 30, 2024$323 $85 $244 $576 $— $1,228 
Effect of foreign currency translation
— — — 1 — 1 
Balance as of June 30, 2025$323 $85 $244 $577 $— $1,229 
(1)Reflects goodwill related to the divestiture of the Argentina business. See Note 2 for additional information.
The changes in the carrying amount of trademarks and other intangible assets for the fiscal years ended June 30, 2025 and 2024 were as follows:
As of June 30, 2025As of June 30, 2024
Gross
carrying
amount		Accumulated
amortization / Impairments		Net carrying
amount		Gross
carrying
amount		Accumulated
amortization / Impairments		Net carrying
amount
Trademarks with indefinite lives
$493 $— $493 $493 $— $493 
Trademarks with finite lives (1)
33 24 9 83 38 45 
Other intangible assets with finite lives (1)
468 404 64 578 435 143 
Total$994 $428 $566 $1,154 $473 $681 
(1)Decrease of Trademarks with finite lives and Other intangible assets with finite lives is primarily related to the divestiture of the Better Health VMS business. See Note 2 for additional information.
Amortization expense relating to the Company’s intangible assets was $21, $29 and $30 for the years ended June 30, 2025, 2024 and 2023, respectively. Estimated amortization expense for these intangible assets is $20, $20, $19, $2 and $2 for fiscal years 2026, 2027, 2028, 2029 and 2030, respectively.
Fiscal Year 2023 Impairments
During the third quarter of fiscal year 2023, management made a decision to narrow the focus on core brands and streamline investment levels in the Better Health VMS business. As a result, revisions were made to the internal financial projections and operational plans of the Better Health VMS business reflecting the Company’s current estimates regarding the future financial performance of these operations and macroeconomic factors. The revised estimated future cash flows reflected lower sales growth expectations and lower investment levels. These revisions were considered a triggering event requiring interim impairment assessments to be performed as part of the preparation of the quarterly financial statements on the global indefinite-lived trademarks, other long-term assets and the Better Health VMS reporting unit. Based on the outcome of these assessments, pre-tax, noncash impairment charges of $445 were recorded during fiscal year 2023. During the first quarter of fiscal year 2025, the Company completed the divestiture of the Better Health VMS business which includes the relevant intangibles. See Note 2 for additional information.
No other significant impairments were identified as a result of the Company's impairment reviews during fiscal years 2025, 2024 and 2023.